Yayın:
Anti‐Metastatic Effects of Aprepitant on Glioblastoma Cells: Targeting the Substance P/Neurokinin‐1 Pathway

Sadeleştirilmiş öğe sayfası
dc.contributor.authorKAYA TİLKİ, ELİF
dc.contributor.authorDikmen, Miriş
dc.contributor.authorMiriş Dikmen
dc.contributor.orcid0000-0003-1534-8117
dc.contributor.orcid0000-0003-2122-5324
dc.contributor.orcid0009-0000-1090-0166
dc.date.accessioned2025-11-13T12:10:36Z
dc.date.issued2025-08-01
dc.identifier.doihttps://doi.org/10.1002/cam4.71148
dc.identifier.endpagee71148
dc.identifier.issn2045-7634
dc.identifier.issue15
dc.identifier.openalexW4413117648
dc.identifier.startpagee71148
dc.identifier.urihttps://hdl.handle.net/11421/9200
dc.identifier.urihttps://doi.org/10.1002/cam4.71148
dc.identifier.volume14
dc.language.isoen
dc.relation.ispartofCancer Medicine
dc.rightsopenAccess
dc.subjectAprepitant
dc.subjectAngiogenesis
dc.subjectCancer research
dc.subjectTachykinin receptor 1
dc.subjectSubstance P
dc.subjectGlioma
dc.subjectExtracellular matrix
dc.subjectInflammation
dc.subjectCell migration
dc.subjectPharmacology
dc.subjectMedicine
dc.subjectBiology
dc.subjectReceptor
dc.subjectCell
dc.subjectImmunology
dc.subjectCell biology
dc.subjectInternal medicine
dc.subjectNeuropeptide
dc.subjectChemotherapy
dc.subject.sdg3
dc.titleAnti‐Metastatic Effects of Aprepitant on Glioblastoma Cells: Targeting the Substance P/Neurokinin‐1 Pathway
dc.typeArticle
dspace.entity.typePublication
local.authorid.openalexA5019197599
local.authorid.openalexA5042645402

Dosyalar

Koleksiyonlar

Publications